115 related articles for article (PubMed ID: 3265362)
1. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
[TBL] [Abstract][Full Text] [Related]
2. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
4. Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage?
Ben-Ezra J; Winberg CD; Wu A; Rappaport H
Hematol Pathol; 1987; 1(3):147-56. PubMed ID: 2472373
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
6. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
9. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasms.
Willman CL; Griffith BB; Whittaker M
Clin Lab Med; 1990 Mar; 10(1):119-49. PubMed ID: 2184975
[TBL] [Abstract][Full Text] [Related]
11. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: an immunologic profile. IV. The EA rosette-forming cell is a Leu-1 positive immunoregulatory B cell.
MacKenzie MR; Paglieroni TG; Warner NL
J Immunol; 1987 Jul; 139(1):24-8. PubMed ID: 2953812
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K
Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523
[TBL] [Abstract][Full Text] [Related]
18. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis.
Knapp W; Strobl H; Majdic O
Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
